Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
04/2003
04/22/2003US6552191 Method of extracting tetrodotoxin
04/22/2003US6552058 Oxazolidinedione derivatives and their use
04/22/2003US6552044 Indane or dihydroindole derivatives
04/22/2003US6552017 Substituted heterocycle fused gamma-carbolines
04/22/2003US6551117 Removable transceiver module
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/17/2003WO2003031447A2 Pyrimidine derivatives
04/17/2003WO2003031444A1 Polycyclic compounds having anti-tumor activity
04/17/2003WO2003031435A1 Pyrazole derivatives as glycine transporter inhibitors
04/17/2003WO2003031429A1 A process for the stereoselective synthesis of 2-hydroxymethyl-chromans
04/17/2003WO1999067238A3 Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003US20030073851 Arylphenyl-substituted cyclic ketoenols
04/17/2003US20030073841 New benzo [b] pyrano [3,2-h] acridin-7-one compounds
04/17/2003US20030073840 Anticancer agents
04/17/2003US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
04/17/2003US20030073703 Autoimmune disease; antiinflammatory agents
04/17/2003US20030073698 Nitrogen-based camptothecin derivatives
04/17/2003US20030073691 Antitumor agents; anticancer agents
04/17/2003US20030073690 Controlling pain in mammals
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives
04/17/2003US20030073582 Fused heterocyclic dicarboxylic acid diamide derivatives or salts thereof, herbicide and method for using the same
04/17/2003US20030073205 Production of polyketides
04/17/2003US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions
04/17/2003US20030071268 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
04/17/2003CA2462156A1 A process for the stereoselective synthesis of 2-hydroxymethyl-chromans
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1053240B1 Glucocorticoid-selective antiinflammatory agents
04/16/2003EP0855398B1 Sesquiterpene derivatives having antiviral activity
04/16/2003CN1410426A Production technology of camptothecin
04/16/2003CN1410425A Derivative containing nitrogen oxygen free radical picropodophyllin
04/16/2003CN1105723C Spirocyclic metalloprotease inhibitors
04/15/2003US6549327 Photochromic gyricon display
04/15/2003US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators
04/15/2003US6548515 Use as anticancer agents
04/15/2003US6548493 Substituted heterocycle fused gamma-carbolines
04/15/2003CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines
04/10/2003WO2003029254A1 Process for preparation of tricyclic compounds
04/10/2003WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
04/10/2003WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
04/10/2003WO2003028733A1 Tetracyclic indole derivatives as 5-ht receptor ligands
04/10/2003WO2002102978A3 Human growth hormone antagonists
04/10/2003WO2002102793A3 Quinazolinediones as antibacterial agents
04/10/2003WO2002048109A8 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators
04/10/2003WO2001083800A3 Heterologous production of polyketides
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069427 Preparing a selective glucocorticoid receptor agents by cyclization, dehalogenation, amination, etherification, hydroxylation
04/10/2003US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group
04/10/2003US20030069276 Viricides; aids therapy
04/10/2003US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders
04/10/2003US20030069257 Benzimidazole and pyridylimidazole derivatives
04/10/2003US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents
04/10/2003US20030069230 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
04/10/2003CA2453343A1 Tetracyclic indole derivatives as 5-ht receptor ligands
04/09/2003EP1300464A1 Fungal cell wall synthesis gene
04/09/2003EP1299394A1 Method for preparing (+)-biotine
04/09/2003EP1299393A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
04/09/2003EP1299392A2 Glucocortiocoid-selective antiinflammatory agents
04/09/2003EP1299391A2 Indolinospiropyran compounds and methods for their manufacture
04/09/2003EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function
04/09/2003EP1299364A1 Benzodiazepines as inhibitors of hpv e1 helicase
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1299360A2 Heterocycle carboxamides as antiviral agents
04/09/2003EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0993458B1 3-benzylpiperidine
04/09/2003EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/09/2003EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives
04/09/2003CN1409713A Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
04/09/2003CN1105115C 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]- spiro [isobenzofuran-1(3H),4'-piperidine)] hydrohalogenides
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/08/2003USRE38073 Biosynthesis; using dehydration agent
04/08/2003US6545033 GABA receptor inhibitors
04/08/2003US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane
04/08/2003US6545014 Glaucoma; adjusting concentration of nitric oxide; hypotensive, antispasmodic, antiischemic, cardiotonic agents; bronchodilators; urogentital disorders; agonists, antagonists for endothelin receptors
04/08/2003US6544982 3-aryl-5-aminoisoxazole derivatives
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2112165C Bicyclic amine derivatives
04/03/2003WO2003027234A2 Small organic molecule regulators of cell proliferation
04/03/2003WO2003027118A1 Pharmaceutically acceptable salts of 20(s)-camptothecins
04/03/2003WO2003027117A1 A process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1h-chromeno[3,4-f]quinolines and derivatives thereof
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027090A2 Bicyclic heterocycles as rxr ligands
04/03/2003WO2003026667A1 Quinazolino- and quinolino- guanidines as ligands for the neurop eptide ff (npff) receptors
04/03/2003WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7
04/03/2003WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
04/03/2003US20030065182 Therapy for asthma, sexual disorders, hypotensive agents, analgesics
04/03/2003US20030065179 Diabetic therapy
04/03/2003US20030065023 Anticancer agents, viricides, psychological disorders
04/03/2003US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
04/03/2003US20030064995 Antidepressants, anxiolytic agents
04/03/2003US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/03/2003US20030064985 Prevent virus reproduction
04/03/2003US20030064982 Pyrazole compounds useful as protein kinase inhibitors
04/03/2003US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease
04/03/2003US20030064491 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents
04/03/2003US20030064332 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
04/03/2003CA2461709A1 Small organic molecule regulators of cell proliferation